Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-06-16FDA Approved: COSENTYX — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Cosentyx (secukinumab) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA [Phase 4]
Phase 4 trial update on withdrawal and re-treatment with etanercept in Nr-axial spondyloarthritis (nr-axial SpA) completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS) [Phase 1, Phase 2]
Phase 1/2a clinical trial of 99mTc-rhAnnexin V-128 in rheumatoid arthritis and ankylosing spondylitis; trial terminated with results posted …
-
FDA approval · 2020-06-01FDA Approved: MELOXICAM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' MELOXICAM as an original-application generic meloxicam; the drug is indicated for relief of pain and inf…
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo [Phase 3]
A Phase 3 study assessing maintenance of sustained remission with CZP versus placebo in axial spondyloarthritis and ankylosing spondylitis h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis [Phase 3]
Phase 3 trial evaluating safety and efficacy of prefixed liquid etanercept (Yisaipu) for active ankylosing spondylitis has completed.
-
FDA approval · 2020-03-19FDA Approved: NAPROXEN — Supplemental Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's supplemental application for naproxen (generic) under ANDA075390. This action constitutes a suppleme…
-
FDA approval · 2020-03-06FDA Approved: CELECOXIB — Original Application (Chartwell RX, LLC)
FDA approved the original generic application for celecoxib (Celecoxib) by Chartwell RX, LLC.
-
FDA approval · 2020-02-25FDA Approved: CELECOXIB — Original Application (EPIC PHARMA, LLC)
FDA approved the Original Application (ANDA) for a generic Celecoxib product from Epic Pharma, LLC, enabling its marketing as a COX-2 inhibi…
-
EMA withdrawal · 2020-02-20EMA Lapsed: Lifmior (etanercept) — Pfizer Europe MA EEIG
The European Medicines Agency indicates Lifmior (etanercept) has lapsed; the product is no longer active in the market for its indicated con…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade
A completed clinical trial evaluating post-marketing use of CT-P13 (infliximab) for standard care in patients with rheumatoid diseases who a…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
Clinical trial update on T cells and TNF blockade in inflammatory diseases; study completed with results posted.
-
FDA approval · 2019-12-06FDA Approved: AVSOLA — Original Application (Amgen, Inc)
FDA approved AVSOLA (infliximab-axxq) from Amgen as a biosimilar to infliximab, for the same indications as the reference product.
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Spondylitis Trial of Apremilast for Better Rheumatic Therapy [Phase 2]
Phase 2 clinical trial update for apremilast in ankylosing spondylitis has completed with results posted.
-
FDA approval · 2019-12-03FDA Approved: DICLOFENAC POTASSIUM — Original Application (Lifsa Drugs LLC)
FDA approved the original application for diclofenac potassium as a generic NSAID for relief of pain and inflammation associated with variou…
-
FDA approval · 2019-11-27FDA Approved: CELECOXIB — Original Application (NIVAGEN PHARMACEUTICALS, INC.)
The FDA approved NIVAGEN Pharmaceuticals, Inc.'s original application for a generic celecoxib product.
-
FDA approval · 2019-11-15FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for a generic Naproxen product from Hikma Pharmaceuticals USA Inc. This action expands access to…
-
FDA approval · 2019-11-14FDA Approved: CELECOXIB — Original Application (Modavar Pharmaceuticals LLC)
The FDA approved Modavar Pharmaceuticals LLC's original application for a generic version of celecoxib (Celecoxib).
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)
Post-marketing observational study evaluating the impact of AbbVie's Patient Support Program on patient-reported outcomes and health resourc…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: 16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis [Phase 3]
Phase 3 trial update reports 16-week efficacy and 5-year long-term efficacy, safety, and tolerability of secukinumab in active ankylosing sp…
-
FDA approval · 2019-10-26FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., resulting in an approved modification to the product’s lab…
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 trial update evaluating a self-injection e-device for certolizumab pegol in several inflammatory diseases; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira [Phase 3]
Phase III trial evaluating BAT1406 compared with Humira in ankylosing spondylitis has completed.
-
FDA approval · 2019-10-09FDA Approved: CELECOXIB — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Celecoxib submitted by Actavis Pharma, Inc.
-
FDA approval · 2019-10-08FDA Approved: OLUMIANT — Supplemental Application (Eli Lilly and Company)
FDA approves Eli Lilly's supplemental application for OLUMIANT (baricitinib). This action updates the labeling to reflect expanded indicatio…